These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1354243)
1. Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells. Izzo AA; North RJ J Exp Med; 1992 Aug; 176(2):581-6. PubMed ID: 1354243 [TBL] [Abstract][Full Text] [Related]
2. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Ladel CH; Daugelat S; Kaufmann SH Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199 [TBL] [Abstract][Full Text] [Related]
3. Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus. Inoue T; Yoshikai Y; Matsuzaki G; Nomoto K J Immunol; 1991 Apr; 146(8):2754-62. PubMed ID: 1707921 [TBL] [Abstract][Full Text] [Related]
4. Mac1 discriminates unusual CD4-CD8- double-negative T cells bearing alpha beta antigen receptor from conventional ones with either CD4 or CD8 in murine lung. Kawakami K; Teruya K; Tohyama M; Kudeken N; Yonamine Y; Saito A Immunol Lett; 1995 May; 46(1-2):143-52. PubMed ID: 7590910 [TBL] [Abstract][Full Text] [Related]
5. Activation of unusual Mac-1+CD4-CD8- T cells bearing (alpha)(beta) antigen receptor in murine lungs during infection with Mycobacterium bovis BCG: regulation by interferon-gamma. Teruya K; Kawakami K; Saito A Microbiol Immunol; 1996; 40(1):45-53. PubMed ID: 8871528 [TBL] [Abstract][Full Text] [Related]
6. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation. Hogan LH; Heninger E; Elsner RA; Vonderheid HA; Hulseberg P; Co D; Sandor M Int Immunol; 2007 May; 19(5):627-33. PubMed ID: 17446212 [TBL] [Abstract][Full Text] [Related]
7. CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin. Feng CG; Britton WJ J Infect Dis; 2000 May; 181(5):1846-9. PubMed ID: 10823799 [TBL] [Abstract][Full Text] [Related]
8. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8. Senaldi G; Shaklee CL; Mak TW; Ulich TR Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057 [TBL] [Abstract][Full Text] [Related]
9. Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Xing Z; Wang J; Croitoru K; Wakeham J Infect Immun; 1998 Nov; 66(11):5537-42. PubMed ID: 9784569 [TBL] [Abstract][Full Text] [Related]
10. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. Hoft DF; Brown RM; Roodman ST J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. de Vallière S; Abate G; Blazevic A; Heuertz RM; Hoft DF Infect Immun; 2005 Oct; 73(10):6711-20. PubMed ID: 16177348 [TBL] [Abstract][Full Text] [Related]
13. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency. Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290 [TBL] [Abstract][Full Text] [Related]
14. A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin). Russell MS; Iskandar M; Mykytczuk OL; Nash JH; Krishnan L; Sad S J Immunol; 2007 Jul; 179(1):211-20. PubMed ID: 17579040 [TBL] [Abstract][Full Text] [Related]
15. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]
16. Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated gamma delta T-cell-depleted mice. Nabeshima S; Hiromatsu K; Matsuzaki G; Mukasa A; Takada H; Yoshida S; Nomoto K Immunology; 1995 Feb; 84(2):317-21. PubMed ID: 7751009 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium genavense infection in normal and immunodeficient mice. Matsiota-Bernard P; Vildé F; Nauciel C Microbes Infect; 2000 May; 2(6):575-80. PubMed ID: 10884607 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
20. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas. Roch F; Bach MA Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]